Share of pharmaceutical revenue of Recordati in H1 of 2023, by segment
In the first half of 2023, pharmaceutical revenues by Italian company Recordati were distributed into two major segments: specialty/primary care and rare diseases. During this period, most of revenues were generated by the specialty and primary care division, with 67 percent, while rare diseases treatments generated 33 percent. This statistic displays the distribution of Recordati's pharmaceutical revenues in H1 of 2023, by segment.